000			01504 a2200421 4500
005			20250513104131.0
264		0	_c19970320
008			199703s 0 0 eng d
022			_a0885-3185
024	7		_a10.1002/mds.870110608 _2doi
040			_aNLM _beng _cNLM
100	1		_aDaum, I
245	0	0	_aClassical eyeblink conditioning in Parkinson's disease. _h[electronic resource]
260			_bMovement disorders : official journal of the Movement Disorder Society _cNov 1996
300			_a639-46 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntiparkinson Agents _xadverse effects
650	0	4	_aArousal _xdrug effects
650	0	4	_aAssociation Learning _xdrug effects
650	0	4	_aCerebral Cortex _xdrug effects
650	0	4	_aConditioning, Classical _xdrug effects
650	0	4	_aConditioning, Eyelid _xdrug effects
650	0	4	_aElectroencephalography _xdrug effects
650	0	4	_aFemale
650	0	4	_aGalvanic Skin Response _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aParkinson Disease _xdrug therapy
700	1		_aSchugens, M M
700	1		_aBreitenstein, C
700	1		_aTopka, H
700	1		_aSpieker, S
773	0		_tMovement disorders : official journal of the Movement Disorder Society _gvol. 11 _gno. 6 _gp. 639-46
856	4	0	_uhttps://doi.org/10.1002/mds.870110608 _zAvailable from publisher's website
999			_c8906570 _d8906570